| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |